Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
InTouch Health: Santa Barbara, Calif.-based firm will use proceeds from a $12.1 mil. Series C financing for ongoing product development and expansion of its sales and marketing team. The firm recently launched its RP-7 remote presence robotic system. The funding was led by Galen Partners, which will contribute two board members, as well as existing investors Acacia Venture Partners and InvestCare Partners. InTouch founder Yulan Wang previously founded robotics company Computer Motion, which merged with Intuitive Surgical in 2003...
You may also be interested in...
Pre-Holiday Savings: Device Firms Prepare For Repatriation Tax Bonanza
Johnson & Johnson intends to "repatriate" as much as $10 bil. held by foreign subsidiaries following President Bush's Oct. 22 signing of the "JOBS" bill into law
MIT Spin-Off Evaluates Vascular Drug Delivery With $500,000 In VC Funds
Pervasis Therapeutics will rely in part on seed money from two Boston venture capital firms to help commercialize a vascular drug delivery device that would promote tissue healing
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”